Bio
Prof. Claudio Cerchione is Head of the Myeloma Clinical and Research Group at IRST IRCCS “Dino Amadori” in Italy and Principal Investigator in numerous company-sponsored and independent clinical trials. He graduated with honors in Medicine from the University Federico II of Naples, where he also completed his Fellowship and PhD in Hematology. His main research interests include multiple myeloma and acute leukemias. He has undertaken international research fellowships in Germany, Portugal, and the USA, including MD Anderson Cancer Center, and has been appointed International Ambassador of SOHO (Society of Hematologic Oncology). He serves as editor and reviewer for several international journals, and has authored more than 150 peer-reviewed publications.

Talk
How I Treat Multiple Myeloma in Europe

Bio
Prof. Claudio Cerchione is Head of the Myeloma Clinical and Research Group at IRST IRCCS “Dino Amadori” in Italy and Principal Investigator in numerous company-sponsored and independent clinical trials. He graduated with honors in Medicine from the University Federico II of Naples, where he also completed his Fellowship and PhD in Hematology. His main research interests include multiple myeloma and acute leukemias. He has undertaken international research fellowships in Germany, Portugal, and the USA, including MD Anderson Cancer Center, and has been appointed International Ambassador of SOHO (Society of Hematologic Oncology). He serves as editor and reviewer for several international journals and has authored more than 150 peer-reviewed publications.

Talk
Early Diagnosis of Myeloma and Frontline Treatment

Bio
Dr Mamta Garg is a Consultant Haematologist at Leicester Royal Infirmary, UK, with expertise in plasma cell disorders and myeloproliferative neoplasms. Her clinical and research interests focus on multiple myeloma, early diagnosis, and improving outcomes in haematological malignancies. She is also involved in national guideline development and clinical research initiatives in haematology.

Talk
Relapsed/Refractory Multiple Myeloma: Key Updates from EHA 2026

Bio
Dr. Vittorio Montefusco earned his MD and specialized in Hematology at the University of Bologna. He spent 20 years at the National Cancer Institute, focusing on bone marrow transplantation and multiple myeloma, and has contributed extensively to clinical research with numerous publications in international journals. Dr. Montefusco is a Board Member of the European Myeloma Network, Italy. Since 2020, he has been with ASST Santi Paolo e Carlo, serving as Acting Head of the Complex Structure of Hematology since 2022.